Beyond Borders: ImmunoACT and India’s Emergence as one of the World’s Most Accessible CAR-T Destination
A patient from Mauritius with relapsed aggressive non-Hodgkin’s lymphoma travelled to India for an indigenously manufactured CAR-T cell therapy by ImmunoACT, a treatment that would...
